ReviewTherapeutics and clinical risk management2019
Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients.
Chin-Chou Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.